Table 1. Comparison of clinical baseline data and pathological features between the two groups before matching.
| Matching variables | GC with diabetes (N=84) | GC only (N=215) | Statistics | P |
|---|---|---|---|---|
| Age | 63.89±8.99 | 58.80±10.59 | 1.770 | 0.187 |
| Gender | 5.999 | 0.016 | ||
| Male | 51 | 154 | ||
| Female | 33 | 61 | ||
| Staging | 10.153 | 0.017 | ||
| I | 16 | 18 | ||
| II | 15 | 32 | ||
| III | 34 | 124 | ||
| IV | 19 | 41 | ||
| Pathological type | 4.291 | 0.232 | ||
| Poorly differentiated adenocarcinoma | 60 | 139 | ||
| Moderately differentiated adenocarcinoma | 22 | 74 | ||
| Highly differentiated adenocarcinoma | 1 | 0 | ||
| Squamous cell carcinoma | 1 | 2 | ||
| Treatment | 14.327 | 0.003 | ||
| Surgery + chemotherapy | 47 | 162 | ||
| Surgery | 16 | 15 | ||
| Chemotherapy | 9 | 21 | ||
| Palliative care | 12 | 17 | ||
| Comorbidity | 14.85 | 0.001 | ||
| None | 46 | 157 | ||
| Cardiovascular disease | 34 | 41 | ||
| Other chronic diseases | 4 | 17 |
GC, gastric cancer.